Trump picks Dr. Heidi Overton, a White House aide, to lead the FDA

Key Points:

• President Donald Trump has nominated Dr. Heidi Overton, a White House Domestic Policy Council deputy director and medical doctor, to lead the Food and Drug Administration (FDA), pending Senate confirmation.
• Overton is known for promoting Trump’s health initiatives, including efforts to lower drug prices and controversial vaccine policies, and has expressed critical views on abortion pills, potentially signaling stricter FDA regulations on medication abortions.
• She will face challenges balancing Trump’s priorities, traditional Republican anti-regulatory interests, and Health Secretary Robert F. Kennedy Jr.’s anti-corporate health agenda, as well as addressing unfinished FDA projects left by former commissioner Dr. Marty Makary.
• Overton’s nomination has drawn criticism from Democrats and some health advocates, who label her as a far-right extremist and question her alignment with scientific consensus, particularly on vaccines and reproductive health.
• Key issues awaiting the new FDA head include regulation of electronic cigarettes, peptide access, ultraprocessed food definitions, vaccine testing protocols, and ongoing investigations into foodborne illness outbreaks.